187 related articles for article (PubMed ID: 35772508)
1. Changes in Spina Bifida Lesion Level after Folic Acid Fortification in the US.
Mai CT; Evans J; Alverson CJ; Yue X; Flood T; Arnold K; Nestoridi E; Denson L; Adisa O; Moore CA; Nance A; Zielke K; Rice S; Shan X; Dean JH; Ethen M; Hansen B; Isenburg J; Kirby RS
J Pediatr; 2022 Oct; 249():59-66.e1. PubMed ID: 35772508
[TBL] [Abstract][Full Text] [Related]
2. Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.
Atta CA; Fiest KM; Frolkis AD; Jette N; Pringsheim T; St Germaine-Smith C; Rajapakse T; Kaplan GG; Metcalfe A
Am J Public Health; 2016 Jan; 106(1):e24-34. PubMed ID: 26562127
[TBL] [Abstract][Full Text] [Related]
3. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002.
Williams LJ; Rasmussen SA; Flores A; Kirby RS; Edmonds LD
Pediatrics; 2005 Sep; 116(3):580-6. PubMed ID: 16140696
[TBL] [Abstract][Full Text] [Related]
4. Countries with an immediate potential for primary prevention of spina bifida and anencephaly: Mandatory fortification of wheat flour with folic acid.
Kancherla V
Birth Defects Res; 2018 Jul; 110(11):956-965. PubMed ID: 29532629
[TBL] [Abstract][Full Text] [Related]
5. Postfolate spina bifida lesion level change.
Eldridge C; Bandlamuri S; Andrews JG; Galindo MK; Contreras D; Flood TJ; Rice S
Birth Defects Res; 2018 Jul; 110(11):949-955. PubMed ID: 29575817
[TBL] [Abstract][Full Text] [Related]
6. Spina bifida before and after folic acid fortification in Canada.
De Wals P; Tairou F; Van Allen MI; Lowry RB; Evans JA; Van den Hof MC; Crowley M; Uh SH; Zimmer P; Sibbald B; Fernandez B; Lee NS; Niyonsenga T
Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):622-6. PubMed ID: 18655127
[TBL] [Abstract][Full Text] [Related]
7. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States.
Boulet SL; Yang Q; Mai C; Kirby RS; Collins JS; Robbins JM; Meyer R; Canfield MA; Mulinare J;
Birth Defects Res A Clin Mol Teratol; 2008 Jul; 82(7):527-32. PubMed ID: 18481813
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.
Williams LJ; Mai CT; Edmonds LD; Shaw GM; Kirby RS; Hobbs CA; Sever LE; Miller LA; Meaney FJ; Levitt M
Teratology; 2002 Jul; 66(1):33-9. PubMed ID: 12115778
[TBL] [Abstract][Full Text] [Related]
9. Preventable spina bifida and anencephaly in Europe.
Obeid R; Pietrzik K; Oakley GP; Kancherla V; Holzgreve W; Wieser S
Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):763-71. PubMed ID: 26178749
[TBL] [Abstract][Full Text] [Related]
10. Folic acid intake and spina bifida in the era of dietary folic acid fortification.
Ahrens K; Yazdy MM; Mitchell AA; Werler MM
Epidemiology; 2011 Sep; 22(5):731-7. PubMed ID: 21659881
[TBL] [Abstract][Full Text] [Related]
11. A 2017 global update on folic acid-preventable spina bifida and anencephaly.
Kancherla V; Wagh K; Johnson Q; Oakley GP
Birth Defects Res; 2018 Aug; 110(14):1139-1147. PubMed ID: 30070772
[TBL] [Abstract][Full Text] [Related]
12. Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S.
Grosse SD; Berry RJ; Mick Tilford J; Kucik JE; Waitzman NJ
Am J Prev Med; 2016 May; 50(5 Suppl 1):S74-S80. PubMed ID: 26790341
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of spina bifida at birth--United States, 1983-1990: a comparison of two surveillance systems.
Lary JM; Edmonds LD
MMWR CDC Surveill Summ; 1996 Apr; 45(2):15-26. PubMed ID: 8602137
[TBL] [Abstract][Full Text] [Related]
14. A 2015 global update on folic acid-preventable spina bifida and anencephaly.
Arth A; Kancherla V; Pachón H; Zimmerman S; Johnson Q; Oakley GP
Birth Defects Res A Clin Mol Teratol; 2016 Jul; 106(7):520-9. PubMed ID: 27418029
[TBL] [Abstract][Full Text] [Related]
15. Effects of folic acid fortification on spina bifida prevalence in Brazil.
Orioli IM; Lima do Nascimento R; López-Camelo JS; Castilla EE
Birth Defects Res A Clin Mol Teratol; 2011 Sep; 91(9):831-5. PubMed ID: 21630426
[TBL] [Abstract][Full Text] [Related]
16. High potential for reducing folic acid-preventable spina bifida and anencephaly, and related stillbirth and child mortality, in Ethiopia.
Dixon M; Kancherla V; Magana T; Mulugeta A; Oakley GP
Birth Defects Res; 2019 Nov; 111(19):1513-1519. PubMed ID: 31424635
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the occurrence of spina bifida (a case-control study) and the prevalence rate of spina bifida in Japan.
Kondo A; Morota N; Ihara S; Saisu T; Inoue K; Shimokawa S; Fujimaki H; Matsuo K; Shimosuka Y; Watanabe T
Birth Defects Res A Clin Mol Teratol; 2013 Sep; 97(9):610-5. PubMed ID: 24078478
[TBL] [Abstract][Full Text] [Related]
18. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011.
Williams J; Mai CT; Mulinare J; Isenburg J; Flood TJ; Ethen M; Frohnert B; Kirby RS;
MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):1-5. PubMed ID: 25590678
[TBL] [Abstract][Full Text] [Related]
19. Update on prevention of folic acid-preventable spina bifida and anencephaly.
Bell KN; Oakley GP
Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):102-7. PubMed ID: 19067404
[TBL] [Abstract][Full Text] [Related]
20. Are encephaloceles neural tube defects?
Rowland CA; Correa A; Cragan JD; Alverson CJ
Pediatrics; 2006 Sep; 118(3):916-23. PubMed ID: 16950981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
